Laura Girardi on Anticoagulant Treatment for Isolated Distal DVT: Finally Our Official Paper Is Out!
Laura Girardi, Clinical and Research Thrombosis Fellow at The Ottawa Hospital, shared on LinkedIn:
”Finally our official paper is out!
An updated systematic review with meta-analysis on management of isolated distal DVT (IDDVT).
Thanks to my fabulous colleagues to have made it possible.
Efficacy outcomes (recurrent DVT, PE, proximal progression of IDDVT and PTS) and safety outcomes (major bleeding and CRNMB) are mainly presented depending on different approaches:
1. No anticoagulation
2. Short duration of anticoagulation (<6 weeks)
3. Long duration (6-12 weeks)
4. Extended-anticoagulation (>12 weeks)
- Patients receiving short courses of anticoagulation had higher risk of recurrent VTE (RR=2.72; 95% CI: 1.19-6.23) and proximal progression (RR=3.86; 95% CI: 1.77-8.43) than patients receiving long anticoagulation, with similar bleeding risk in patients with IDDVT.
- Anticoagulation seemed associated with lower risk of recurrent VTE and proximal progression, and similar bleeding risk compared to no anticoagulant treatment.
- The incidence of PTS was 30% in untreated patients, 11% in short, and 0% in long anticoagulation.
- Long-term treatment duration appeared to be more effective.
Please find more details (e.g. dose and type of anticoagulation, baseline patients’ risks, etc.) in the full text!”
Read the full article in Haematologica.
Article: Anticoagulant treatment for isolated distal deep vein thrombosis: a systematic review and meta-analysis
Authors: Matteo Guarascio, Emanuele Valeriani, Laura Girardi, Matteo Candeloro, Arianna Pannunzio, Ilaria Maria Palumbo, Marcello Di Nisio, Walter Ageno
Stay updated on all scientific advances in the field of thrombosis with Hemostasis Today.
-
Apr 7, 2026, 19:17Anand Padmanabhan: Persistence and Pathogenicity of Platelet Factor 4 Antibodies in VITT
-
Apr 7, 2026, 19:07Clara Meijs: Great Time Presenting Our Endometriosis Project at the AHA EPI Lifestyle Conference
-
Apr 7, 2026, 18:18Vivek Das: How Obesity, Type 2 Diabetes, and Dyslipidaemia Interact Across Multiple Cardiovascular Conditions
-
Apr 7, 2026, 17:44Augustina Isioma Ikusemoro: Quality Indicators for Red Blood Cells in Transfusion Medicine
-
Apr 7, 2026, 17:35Nikola Grubor: In Situ Pulmonary Arterial Thrombosis Mimicking CTEPH in Eisenmenger
-
Apr 7, 2026, 17:34Pooja Choradia: vWF Breakdown in Aortic Stenosis – Anaemia and Pulmonary Relevance
-
Apr 7, 2026, 17:32Wolfgang Miesbach: Exceptional Presentation on the Role of vWF in Angiogenesis and Gut Angiodysplasia in VWD
-
Apr 7, 2026, 17:30Chokri Ben Lamine: No Routine VTE Prophylaxis for Chronically Bedridden Patients at Home
-
Apr 7, 2026, 17:28Amanda Johnson: The Stretch of Science in the History of EDS